Compile Data Set for Download or QSAR
Report error Found 78 Enz. Inhib. hit(s) with all data for entry = 50015986
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591075(CHEMBL5200118)
Affinity DataIC50: 2nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591046(CHEMBL5202342)
Affinity DataIC50: 3nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591045(CHEMBL5209076)
Affinity DataIC50: 5nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591066(CHEMBL5190023)
Affinity DataIC50: 5nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591054(CHEMBL5179922)
Affinity DataIC50: 5nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591079(CHEMBL5196751)
Affinity DataIC50: 8nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591070(CHEMBL5208600)
Affinity DataIC50: 8nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591075(CHEMBL5200118)
Affinity DataIC50: 9nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591081(CHEMBL5193210)
Affinity DataIC50: 10nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591044(CHEMBL5202445)
Affinity DataIC50: 11nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591077(CHEMBL5201930)
Affinity DataIC50: 15nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591072(CHEMBL5172690)
Affinity DataIC50: 16nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591065(CHEMBL5170361)
Affinity DataIC50: 16nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591066(CHEMBL5190023)
Affinity DataIC50: 16nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591065(CHEMBL5170361)
Affinity DataIC50: 16nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591064(CHEMBL5199369)
Affinity DataIC50: 17nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591054(CHEMBL5179922)
Affinity DataIC50: 20nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591059(CHEMBL5195519)
Affinity DataIC50: 21nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591064(CHEMBL5199369)
Affinity DataIC50: 21nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591063(CHEMBL5180017)
Affinity DataIC50: 21nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591043(CHEMBL5199283)
Affinity DataIC50: 23nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591063(CHEMBL5180017)
Affinity DataIC50: 25nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591072(CHEMBL5172690)
Affinity DataIC50: 25nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591067(CHEMBL5201758)
Affinity DataIC50: 27nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591081(CHEMBL5193210)
Affinity DataIC50: 29nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591078(CHEMBL5195933)
Affinity DataIC50: 29nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591070(CHEMBL5208600)
Affinity DataIC50: 33nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591079(CHEMBL5196751)
Affinity DataIC50: 35nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591050(CHEMBL5197413)
Affinity DataIC50: 40nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591060(CHEMBL5199088)
Affinity DataIC50: 43nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591061(CHEMBL5175719)
Affinity DataIC50: 55nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591042(CHEMBL5183235)
Affinity DataIC50: 56nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591073(CHEMBL5176674)
Affinity DataIC50: 61nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591051(CHEMBL5183990)
Affinity DataIC50: 61nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591055(CHEMBL5200952)
Affinity DataIC50: 74nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591068(CHEMBL5188650)
Affinity DataIC50: 76nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591080(CHEMBL5189372)
Affinity DataIC50: 78nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591041(CHEMBL5178602)
Affinity DataIC50: 81nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591050(CHEMBL5197413)
Affinity DataIC50: 86nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591062(CHEMBL5189317)
Affinity DataIC50: 90nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591071(CHEMBL5177614)
Affinity DataIC50: 91nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetMitogen-activated protein kinase 10(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591066(CHEMBL5190023)
Affinity DataIC50: 101nMAssay Description:Inhibition of JNK3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591058(CHEMBL5180483)
Affinity DataIC50: 106nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591060(CHEMBL5199088)
Affinity DataIC50: 106nMAssay Description:Inhibition of GCN2 in human SK-OV-3 cells assessed as reduction in phosphorylation of eIF2alpha by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591076(CHEMBL5194671)
Affinity DataIC50: 109nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCyclin-dependent kinase-like 4(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591066(CHEMBL5190023)
Affinity DataIC50: 118nMAssay Description:Inhibition of CDKL4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetTranscription initiation factor TFIID subunit 1-like(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591066(CHEMBL5190023)
Affinity DataIC50: 124nMAssay Description:Inhibition of TAF1L (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591040(CHEMBL5208897)
Affinity DataIC50: 133nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCyclin-dependent kinase-like 3(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591066(CHEMBL5190023)
Affinity DataIC50: 143nMAssay Description:Inhibition of CDKL3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargeteIF-2-alpha kinase GCN2(Human)
Rapt Therapeutics

Curated by ChEMBL
LigandPNGBDBM50591053(CHEMBL5196192)
Affinity DataIC50: 144nMAssay Description:Inhibition of GCN2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
Displayed 1 to 50 (of 78 total ) | Next | Last >>
Jump to: